Donald R. Bullock

All filings by Donald R. Bullock on record concern Sagent Pharmaceuticals, Inc. Between 27 June 2016 and 29 August 2016, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 31 August 2016, reports a transaction of €50k in Sagent Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.